Bright Minds Biosciences Inc. lost $0.48 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Bright Minds Biosciences Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Bright Minds Biosciences Inc.'s diluted earnings per share in fiscal year 2024?
Bright Minds Biosciences Inc. lost $0.48 per diluted share in fiscal year 2024.
How fast is Bright Minds Biosciences Inc.'s diluted earnings per share growing?
Bright Minds Biosciences Inc. (DRUG) reported a loss of $1.46 per diluted share in fiscal year 2023 and a loss of $0.48 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Bright Minds Biosciences Inc.'s diluted earnings per share changed over the years?
Across the 5 fiscal years this page covers, Bright Minds Biosciences Inc. (DRUG) diluted earnings per share went from -$0.10 in fiscal year 2020 to -$0.48 in fiscal year 2024.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Bright Minds Biosciences Inc. (DRUG) reported on that line in every period on record.
